Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469519 · ClinicalTrials.gov registry record · Phase 2
Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes
A Phase 2 study, sponsored by Pediatrix.
- Completed
- Registry status
- Phase 2
- Development phase
- 194
- Enrollment target
NCT02469519 is a Phase 2 study that has completed, run by Pediatrix. The registered enrollment target is 194 participants.
The verdict
NCT02469519, a Phase 2 study, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 194 participants
- Enrollment target
Study Summary
This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes.
Interventions
- DRUG Betamethasone - ACTIVE
- OTHER Normal Saline - PLACEBO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2016-03-03 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469519
The ClinicalTrials.gov registry entry for NCT02469519 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Betamethasone - ACTIVE is the first listed.
NCT02469519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02469519 about?
NCT02469519 is a clinical study titled "Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes". This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes.
What is the current status of trial NCT02469519?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 194 participants. The study started on 2016-03-03. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT02469519?
The interventions under investigation include: Betamethasone - ACTIVE (DRUG), Normal Saline - PLACEBO (OTHER).
Who is sponsoring clinical trial NCT02469519?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.